Champions Oncology (CSBR) to Release Earnings on Thursday

Champions Oncology (NASDAQ:CSBR) will post its quarterly earnings results after the market closes on Thursday, December 7th.

Champions Oncology (NASDAQ:CSBR) last announced its quarterly earnings data on Thursday, September 14th. The biotechnology company reported ($0.06) earnings per share for the quarter. The business had revenue of $5.03 million during the quarter. Champions Oncology had a negative net margin of 29.87% and a negative return on equity of 338.01%.

Champions Oncology (CSBR) opened at $3.68 on Wednesday. Champions Oncology has a twelve month low of $2.09 and a twelve month high of $4.79.

TRADEMARK VIOLATION NOTICE: “Champions Oncology (CSBR) to Release Earnings on Thursday” was posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this article on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The legal version of this article can be accessed at

About Champions Oncology

Champions Oncology, Inc is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans.

Earnings History for Champions Oncology (NASDAQ:CSBR)

Receive News & Ratings for Champions Oncology Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Champions Oncology Inc and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply